Literature DB >> 18779610

Stemming the tide of cancer for BRCA1/2 mutation carriers.

Henry T Lynch, Joseph N Marcus, Wendy S Rubinstein.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18779610      PMCID： PMC2627775          DOI： 10.1200/JCO.2008.17.4201

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  48 in total

1.  Prognosis of BRCA1 hereditary breast cancer.

Authors:  P Watson; J N Marcus; H T Lynch
Journal:  Lancet       Date:  1998-01-31       Impact factor: 79.321

2.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

Authors:  J Peto; N Collins; R Barfoot; S Seal; W Warren; N Rahman; D F Easton; C Evans; J Deacon; M R Stratton
Journal:  J Natl Cancer Inst       Date:  1999-06-02       Impact factor: 13.506

3.  A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.

Authors:  Carla C Wárlám-Rodenhuis; Veronica C M Koot; Rob B van der Luijt; Hans F A Vasen; Margreet G E M Ausems
Journal:  Eur J Cancer       Date:  2005-07       Impact factor: 9.162

4.  Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.

Authors:  J L Hopper; M C Southey; G S Dite; D J Jolley; G G Giles; M R McCredie; D F Easton; D J Venter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-09       Impact factor: 4.254

5.  Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.

Authors: 
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

6.  Inherited BRCA2 mutation associated with high grade breast cancer.

Authors:  B A Agnarsson; J G Jonasson; I B Björnsdottir; R B Barkardottir; V Egilsson; H Sigurdsson
Journal:  Breast Cancer Res Treat       Date:  1998-01       Impact factor: 4.872

7.  Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.

Authors:  T R Rebbeck; A M Levin; A Eisen; C Snyder; P Watson; L Cannon-Albright; C Isaacs; O Olopade; J E Garber; A K Godwin; M B Daly; S A Narod; S L Neuhausen; H T Lynch; B L Weber
Journal:  J Natl Cancer Inst       Date:  1999-09-01       Impact factor: 13.506

8.  Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.

Authors:  A Catteau; W H Harris; C F Xu; E Solomon
Journal:  Oncogene       Date:  1999-03-18       Impact factor: 9.867

9.  Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.

Authors:  Sunil R Lakhani; Jorge S Reis-Filho; Laura Fulford; Frederique Penault-Llorca; Marc van der Vijver; Suzanne Parry; Timothy Bishop; Javier Benitez; Carmen Rivas; Yves-Jean Bignon; Jenny Chang-Claude; Ute Hamann; Cees J Cornelisse; Peter Devilee; Matthias W Beckmann; Carolin Nestle-Krämling; Peter A Daly; Neva Haites; Jenny Varley; Fiona Lalloo; Gareth Evans; Christine Maugard; Hanne Meijers-Heijboer; Jan G M Klijn; Edith Olah; Barry A Gusterson; Silvana Pilotti; Paolo Radice; Siegfried Scherneck; Hagay Sobol; Jocelyne Jacquemier; Teresa Wagner; Julian Peto; Michael R Stratton; Lesley McGuffog; Douglas F Easton
Journal:  Clin Cancer Res       Date:  2005-07-15       Impact factor: 12.531

10.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779
View more
  1 in total

Review 1.  Oncogenes and tumor suppressor genes.

Authors:  Eva Y H P Lee; William J Muller
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-18       Impact factor: 10.005
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.